Clinical Trials Logo

Clinical Trial Summary

This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.


Clinical Trial Description

This study will evaluate the safety and effectiveness of the CloudCath System to detect the onset of peritonitis as compared to standard of care. Study Participants will connect the CloudCath System to their home peritoneal dialysis unit and the CloudCath System will analyze the effluent dialysis solution for changes associated with peritonitis. The notification capability of the CloudCath System will be deactivated for this study so that neither Study Participants nor Study Investigators will be aware of the device measurements. Following enrollment, Study Participants will use the CloudCath System for 12 continuous months. ;


Study Design


Related Conditions & MeSH terms

  • Peritoneal Dialysis-associated Peritonitis
  • Peritonitis

NCT number NCT04515498
Study type Observational
Source CloudCath
Contact
Status Completed
Phase
Start date August 19, 2020
Completion date March 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03264625 - The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Phase 2
Suspended NCT05300191 - In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device
Completed NCT03685747 - Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis Phase 1
Recruiting NCT03046511 - Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter. Phase 3
Recruiting NCT05285436 - A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis N/A
Recruiting NCT05971537 - Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis Phase 4
Recruiting NCT05860270 - Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis Phase 4
Completed NCT01293799 - Prevention of Peritonitis in Peritoneal Dialysis N/A
Withdrawn NCT03675854 - Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis Phase 4
Completed NCT05450523 - Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol
Terminated NCT00801775 - Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry N/A